Gene: RBL2
Official Full Name: RB transcriptional corepressor like 2provided by HGNC
Gene Summary: Enables promoter-specific chromatin binding activity. Involved in regulation of lipid kinase activity. Acts upstream of or within negative regulation of gene expression. Located in chromosome; cytosol; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10156 | RBL2 Knockout cell line (HeLa) | Human | RBL2 | 1:3~1:6 | Negative | Online Inquiry |
KO10157 | RBL2 Knockout cell line (HCT 116) | Human | RBL2 | 1:2~1:4 | Negative | Online Inquiry |
KO10158 | RBL2 Knockout cell line (HEK293) | Human | RBL2 | 1:3~1:6 | Negative | Online Inquiry |
KO10159 | RBL2 Knockout cell line (A549) | Human | RBL2 | 1:3~1:4 | Negative | Online Inquiry |
RBL2 Gene Knockout Cell Lines are engineered cell models designed to specifically silence the RBL2 (Retinoblastoma-Like 2) gene, which encodes a protein that plays a crucial role in cell cycle regulation and tumor suppression. By utilizing CRISPR/Cas9 technology, these cell lines provide a precise and efficient means of exploring the functional implications of RBL2 loss in various biological contexts. The unique knockout configuration facilitates the study of cell proliferation, differentiation, and apoptosis, allowing researchers to dissect the pathways influenced by RBL2 activity.
The mechanism of action involves targeted genomic editing, where the RBL2 gene is disrupted, leading to the loss of its protein product. This disruption enables scientists to observe resultant phenotypic changes and understand the gene's role in cellular processes. In particular, RBL2 is implicated in oncogenic processes, making these knockout cell lines invaluable for cancer research, drug discovery, and therapeutic development. By studying these cell lines, researchers can identify potential biomarkers for cancer progression and devise innovative therapeutic strategies.
One of the primary benefits of RBL2 Gene Knockout Cell Lines is their specificity and reproducibility compared to other methods such as RNA interference, which may present off-target effects. Additionally, these cell lines are ready-to-use, ensuring that researchers can expedite their investigations without the need for extensive preliminary modifications. The reliability of results obtained from such models makes them indispensable tools for both academic research institutions and clinical laboratories.
In summary, RBL2 Gene Knockout Cell Lines represent a powerful asset for researchers and clinicians aiming to elucidate the intricacies of cell regulation and tumorigenesis. Supported by our company’s extensive experience in genetic modification technologies and a commitment to advancing the field of molecular biology, we provide high-quality products backed by rigorous scientific validation to support your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.